Companies · AI / ML
San Francisco · CA, USA · AI / ML · founded 2015 · http://klarismo.com
Diligence memoA one-page analyst read on Klarismo — recommendation, valuation, rhythm, risks.→Klarismo: limited disclosed financing to assess.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
Klarismo is one of 2067 AI / ML companies tracked from San Francisco, CA, USA, on record since 2015. By capital raised it ranks mid-pack (ahead of 62% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Klarismo turns your body into an interactive experience. We built a…
Fully-automated Quantitative MR Image Analysis. Our software converts a user’s full body magnetic resonance scan (MRI) into a 3D virtual model of their body in the cloud. The model is annotated with explanatory information so they can easily explore and learn about different parts of their body. Klarismo is the only provider of MR analytics that can offer truly scalable analysis for large data collections. Cloud-based processing allows 1000s of acquisitions to be analyzed simultaneously. Machine learning techniques utilize Klarismo’s proprietary collection of labelled MRI data and eliminate the need for manual processing to produce precise volumetric measurements. Klarismo specializes in the detailed analysis of body composition, including volumetric measurements of different muscle and fat tissues, from whole-body acquisitions.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
No round amounts on record to chart.
No staged rounds to sequence.
Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 2067 companies in AI / ML. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 62% of sector peers (real $). Modeled value above 62% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| No rounds recorded. | |||||
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Klarismo is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Accord | AI / ML | — | — | — | same sector |
| Acely | AI / ML | — | — | — | same sector |
| Aedilic | AI / ML | — | — | — | same sector |
| Aemon | AI / ML | — | — | — | same sector |
| Affogato AI | AI / ML | — | — | — | same sector |
| Aftercare | AI / ML | — | — | — | same sector |
| Agentic Labs | AI / ML | — | — | — | same sector |
| Ai Aiba | AI / ML | — | — | — | same sector |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| iSono Health, Inc. AI-powered platform for Accessible and Personalized Breast Health… | Medical Devices | Seed | $6.7M | 77% |
| Klarify AI Agent for Therapists | Insurance | — | — | 75% |
| Klarity Company Brain for people and agents to work in harmony. | AI / ML | — | — | 75% |
| MICSI Higher resolution MRI with faster scan times. | Healthtech | — | — | 74% |
| AgileMD Predictive analytics and clinical pathways for hospitals | Healthtech | — | — | 74% |
| Mecha Health Foundation models to automate x-ray analysis for radiologists | Healthtech | — | — | 73% |
| Klarity Intelligence, Inc. | AI / ML | Series B | $456.7M | 73% |
| Astraea, Inc. AI Operating System for Clinical Development | AI / ML | Series A | $93.3M | 72% |
See where Klarismo sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Klarismo, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.